Pay in 4 interest-free payments of $30.25 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The 4-Hydroxyphenylacetic acid pretreatment at a final dose of 25 mg/kg markedly and selectively up-regulated the target genes of phase II enzymes and resulted in higher up-regulation than that of the control group by 270%
Smiles: C[C@@H](CC)[C@H](/N=C(\O)/[C@H](CCC(O)=O)/N=C(\O)/[C@@H](/N=C(\O)/[C@H](CCC(=N)O)/N=C(\O)/[C@@H](N)CCCCN)[C@@H](C)CC)/C(/O)=N/[C@@H](CCCCN)/C(/O)=N/[C@@H](CCCCN)/C(/O)=N/[C@@H](CC1C=CC=CC=1)/C(/O)=N/[C@@H](CCCCN)C(O)=O
Lipsanen A
especially in non-small cell lung cancer
CAS Number: 2305369-00-8
217-82-3 RP human The 4-Hydroxyphenylacetic acid pretreatment atProduct information CAS Number: 217 82 3 Molecular Weight: 232. 24 Formula: C14H8N4 Chemical Name: Pyrazino[2, 3 f][4, 7]phenanthroline Smiles: C1=CC=NC2=C3N=CC=NC3=C3N=CC=CC3=C21 InChiKey: NVFJXZGVAGNQDD UHFFFAOYSA N InChi: InChI=1S C14H8N4 c1 3 9 10 4 2 6 16 12(10)14 13(11(9)15 5 1)17 7 8 18 14 h1 8H Technical Data Appearance: Solid Power Purity: 98% (or refer to the Certificate of Analysis) Solubility: To be determined Shipping Condition: Shipped
US$ 181.50
US$ 353.50
US$ 1326.00
US$ 166.00
US$ 142.00
US$ 197.50
US$ 108.50
US$ 169.00
US$ 369.05
US$ 142.00
US$ 142.00
US$ 197.00
US$ 112.00